TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers identified 17 plasma proteins associated with all-cause mortality in older adults, using data from two longitudinal cohorts. Several proteins were also associated with biological-age measures, but the study does not show that they cause aging or can predict an individual’s lifespan.
Researchers have identified 17 plasma proteins associated with all-cause mortality in older adults, with several also linked to measures of biological aging across the body and specific organs. The study, published in Geromedicine, analyzed blood-protein data from one cohort and independently evaluated key findings in a second, but it does not establish that the proteins cause aging or can predict an individual’s lifespan.
The researchers measured 4,265 proteins in blood samples from 1,025 older adults in the LonGenity study. Participants were followed for an average of 8.05 years. Using statistical models, the team examined whether protein levels were associated with death from any cause, then investigated links with chronic disease burden and proteome-derived measures of biological age.
Higher levels of ERBB1, also called the epidermal growth factor receptor, and ANTXR2 were associated with lower mortality risk and younger biological-age measures across multiple organ systems. By contrast, higher levels of MIC-1/GDF15, HE4 and IGFBP-2 were associated with higher mortality risk and older biological age across multiple systems.
The report also described more specific patterns: elevated MIC-1/GDF15 was associated with older organismal biological age, while ERBB1 was associated with younger liver biological age. The researchers evaluated their findings in 1,124 participants from the Baltimore Longitudinal Study of Aging, where key associations were independently replicated.
Protein Patterns Across Aging Systems
The findings connect mortality-associated blood proteins with measures intended to capture how aging varies between people and across organs. Chronological age records years lived, but biological-age measures aim to reflect differences in physiological condition. The overlap reported here gives researchers candidates for studying how systemic stress, chronic disease and physiological regulation relate to aging.
The results may guide further work on biomarkers and biological pathways, but they are not a clinical test. The study does not show that measuring these proteins can determine a person’s health outlook, nor that changing their levels would reduce mortality. For readers, the distinction is important: these are statistical associations, not proven causes or individual forecasts.
Products Worth Considering
Withings BPM Connect Smart Blood Pressure Monitor
Withings BPM Vision Blood Pressure Monitor with Wi-Fi and Bluetooth
Bowflex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
Two Cohorts, One Protein Analysis
The study addresses a question in geroscience: why people of the same chronological age can differ in health, disease burden and resilience. To investigate it, the team compared plasma-protein levels with mortality outcomes and with biological-age measures at both whole-body and organ-specific levels. The analysis used Cox proportional-hazards models to examine associations with all-cause mortality.
Researchers first identified associations in the LonGenity cohort, then tested key results in participants from the Baltimore Longitudinal Study of Aging. This second-cohort evaluation strengthens the evidence that the reported associations were not confined to the initial group, although replication does not establish causation or clinical usefulness. The open-access paper is titled “Exploring mortality-linked proteins: Understanding their association with biological aging, disease phenotypes, signaling pathways, and their implications for longevity.”
Associations, Not Individual Predictions
The study does not establish whether the proteins contribute to aging or mortality, or whether their levels change in response to other processes. The reported associations cannot show that a protein is a cause of a health outcome. The authors identify the proteins as candidates for further investigation, rather than validated tools for clinical decision-making.
The source report does not provide enough detail to assess how well any protein would predict outcomes for an individual, what thresholds might be meaningful, or whether testing could improve care. It also does not establish that the findings apply beyond the older-adult cohorts studied. No lifespan-prediction test or treatment recommendation follows from these results.
Further Testing of Candidate Biomarkers
The next steps are further research into the biological mechanisms behind the protein associations and evaluation of whether they hold across other populations and study settings. Researchers would also need to determine whether these measures add useful information beyond existing health and disease indicators.
Clinical use would require separate evidence that a test is reliable, meaningful for patient outcomes and appropriate for medical decisions. For now, the study’s contribution is to identify candidate proteins and pathways for additional mechanistic and clinical investigation; the report does not announce a diagnostic test or a planned clinical application.
Key Questions
How many proteins were associated with mortality?
The researchers identified 17 plasma proteins significantly associated with all-cause mortality in their analysis of older adults.
Which proteins were linked to lower mortality risk?
Higher levels of ERBB1 and ANTXR2 were associated with lower mortality risk and younger biological-age measures across multiple organ systems. These are associations, not evidence that the proteins lower risk.
Which proteins were linked to higher mortality risk?
Higher levels of MIC-1/GDF15, HE4 and IGFBP-2 were associated with higher mortality risk and older biological-age measures across multiple systems.
Can these findings predict how long a person will live?
No. The study did not provide a clinical blood test for predicting an individual’s lifespan or disease outcome. It reported statistical associations in two longitudinal cohorts.
Were the findings checked in another group?
Yes. Key associations were independently evaluated in 1,124 participants from the Baltimore Longitudinal Study of Aging after the initial analysis of 1,025 LonGenity participants.
Source: news-medical.net
